Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2003-7-9
pubmed:abstractText
Reasons for development of bacillus Calmette-Guerin(BCG)-refractory superficial bladder cancers are unknown. In the present study, a series of cases was therefore analyzed, focusing on the influence of treatment before BCG application.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1341-9625
pubmed:author
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
168-73
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12851841-Administration, Intravesical, pubmed-meshheading:12851841-Adult, pubmed-meshheading:12851841-Aged, pubmed-meshheading:12851841-Aged, 80 and over, pubmed-meshheading:12851841-BCG Vaccine, pubmed-meshheading:12851841-Biopsy, Needle, pubmed-meshheading:12851841-Carcinoma, Transitional Cell, pubmed-meshheading:12851841-Cohort Studies, pubmed-meshheading:12851841-Cystectomy, pubmed-meshheading:12851841-Female, pubmed-meshheading:12851841-Humans, pubmed-meshheading:12851841-Male, pubmed-meshheading:12851841-Middle Aged, pubmed-meshheading:12851841-Neoplasm Recurrence, Local, pubmed-meshheading:12851841-Neoplasm Staging, pubmed-meshheading:12851841-Probability, pubmed-meshheading:12851841-Prognosis, pubmed-meshheading:12851841-Proportional Hazards Models, pubmed-meshheading:12851841-Retrospective Studies, pubmed-meshheading:12851841-Risk Assessment, pubmed-meshheading:12851841-Survival Rate, pubmed-meshheading:12851841-Treatment Outcome, pubmed-meshheading:12851841-Urinary Bladder Neoplasms
pubmed:year
2003
pubmed:articleTitle
Bacillus Calmette-Guerin-refractory superficial bladder cancers: focus on pretreatment episodes.
pubmed:affiliation
The Urology Division, Meijo Hospital, 1-3-1 San-nomaru, Naka-ku, Nagoya 460-0001, Japan. hiko0512@yahoo.co.jp
pubmed:publicationType
Journal Article